Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QP-6211 for postoperative pain after hallux valgus surgery (Phase II)
ChiCTR2600119167Phase 2Completed
- Sponsor
- Beijing Jishuitan Hospital
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of QP-6211 in postoperative pain (4 arms), sponsored by Beijing Jishuitan Hospital. Primary endpoints: Area under the curve (AUC) of NRS-R pain intensity scores and Area under the curve (AUC) of NRS-A pain intensity scores. Started Feb 2026; status: completed.
02
Drugs
QP-6211
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600119167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119167.